{"id":4831,"date":"2025-09-19T07:13:24","date_gmt":"2025-09-19T05:13:24","guid":{"rendered":"https:\/\/hepc.ch\/swiss-hepatitis-symposium-2025\/"},"modified":"2025-10-03T13:13:57","modified_gmt":"2025-10-03T11:13:57","slug":"swiss-hepatitis-symposium-2025","status":"publish","type":"post","link":"https:\/\/hepc.ch\/fr\/swiss-hepatitis-symposium-2025\/","title":{"rendered":"Swiss Hepatitis Symposium 2025"},"content":{"rendered":"<p>Le Symposium suisse sur l&rsquo;h\u00e9patite 2025 aura lieu le lundi 8 d\u00e9cembre 2025, de 13h30 \u00e0 18h00, au Welle 7 \u00e0 Berne.<\/p>\n<p>Le th\u00e8me du symposium de cette ann\u00e9e est le suivant :<br \/>\n\u00ab H\u00e9patite virale : micro-\u00e9limination chez les personnes suivant un traitement aux agonistes opio\u00efdes et les consommateurs de substances \u00bb.<\/p>\n<p>Le symposium se concentrera sur les th\u00e8mes suivants :<br \/>\n&#8211; Identification des obstacles pratiques aux tests et aux traitements dans les centres OAT d\u00e9centralis\u00e9s.<br \/>\n&#8211; \u00c9change d&rsquo;approches et de perspectives internationales et nationales sur ce th\u00e8me.<br \/>\n&#8211; Mise en r\u00e9seau des parties prenantes et d\u00e9veloppement de solutions communes.<\/p>\n<p>Veuillez r\u00e9server cette date d\u00e8s aujourd&rsquo;hui. La participation au symposium est gratuite. L&rsquo;\u00e9v\u00e9nement se terminera par un ap\u00e9ritif commun, qui sera l&rsquo;occasion d&rsquo;approfondir les contacts nou\u00e9s au cours de la journ\u00e9e.<\/p>\n<p>Programme <a href=\"https:\/\/hepc.ch\/wp_live17\/wp-content\/uploads\/2025\/10\/swiss-hepa-symp-25.pdf\" rel=\"noopener nofollow \" target=\"_blank\">PDF<\/a><\/p>\n<p><a href=\"https:\/\/hepatitis-schweiz.ch\/\" target=\"_blank\" rel=\"noopener nofollow\">H\u00e9patite Suisse<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le Symposium suisse sur l&rsquo;h\u00e9patite 2025 aura lieu le lundi 8 d\u00e9cembre 2025, de 13h30 \u00e0 18h00, au Welle 7 \u00e0 Berne. Le th\u00e8me du symposium de cette ann\u00e9e est le suivant : \u00ab H\u00e9patite virale : micro-\u00e9limination chez les personnes suivant un traitement aux agonistes opio\u00efdes et les consommateurs de substances \u00bb. Le symposium\u2026 <span class=\"read-more\"><a href=\"https:\/\/hepc.ch\/fr\/swiss-hepatitis-symposium-2025\/\">Read More &raquo;<\/a><\/span><\/p>\n","protected":false},"author":1,"featured_media":4822,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-4831","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-classifiee"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/hepc.ch\/fr\/wp-json\/wp\/v2\/posts\/4831","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hepc.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hepc.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hepc.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/hepc.ch\/fr\/wp-json\/wp\/v2\/comments?post=4831"}],"version-history":[{"count":3,"href":"https:\/\/hepc.ch\/fr\/wp-json\/wp\/v2\/posts\/4831\/revisions"}],"predecessor-version":[{"id":4848,"href":"https:\/\/hepc.ch\/fr\/wp-json\/wp\/v2\/posts\/4831\/revisions\/4848"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hepc.ch\/fr\/wp-json\/wp\/v2\/media\/4822"}],"wp:attachment":[{"href":"https:\/\/hepc.ch\/fr\/wp-json\/wp\/v2\/media?parent=4831"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hepc.ch\/fr\/wp-json\/wp\/v2\/categories?post=4831"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hepc.ch\/fr\/wp-json\/wp\/v2\/tags?post=4831"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}